TRCNF (Transnational Cannabis) General and Admin. Expense: $35.25 Mil (TTM As of Nov. 2019)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Transnational Cannabis General and Admin. Expense?

Transnational Cannabis TRCNF -97.50% General and Admin. Expense is $35.25 Mil as of Nov. 2019.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Transnational Cannabis's General and Admin. Expense for the three months ended in Nov. 2019 was $1.87 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Nov. 2019 was $35.25 Mil.

Transnational Cannabis General and Admin. Expense Related Terms

Transnational Cannabis General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Transnational Cannabis's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Transnational Cannabis General and Admin. Expense Chart

Transnational Cannabis Annual Data
Trend Feb10 Feb11 Feb12 Feb13 Feb14 Feb15 Feb16 Feb17 Feb18 Feb19
General and Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.36 0.20 0.30 0.78 27.61

Transnational Cannabis Quarterly Data
Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.73 15.85 7.59 9.93 1.87

Transnational Cannabis General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Nov. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $35.25 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of $35.25 Mil mean?
Transnational Cannabis (TRCNF) has a General and Admin. Expense of $35.25 Mil as of Nov. 2019. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Transnational Cannabis and its competitors.
Is Transnational Cannabis' General and Admin. Expense too high?
Transnational Cannabis' current General and Admin. Expense is $35.25 Mil.
How does Transnational Cannabis' General and Admin. Expense compare to CLSH and KAYS?
Transnational Cannabis' General and Admin. Expense of $35.25 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Drug Manufacturers company?
A good General and Admin. Expense depends on the Drug Manufacturers industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Transnational Cannabis and its competitors. Transnational Cannabis's current General and Admin. Expense is $35.25 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Transnational Cannabis stock overvalued right now?
Transnational Cannabis (TRCNF) has a current General and Admin. Expense of $35.25 Mil. The current General and Admin. Expense is $35.25 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For Transnational Cannabis (TRCNF), the current General and Admin. Expense is $35.25 Mil as of Nov. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Transnational Cannabis Business Description

Address 37 King Street East, Suite 409, Toronto, ON, CAN, M5C 1E9
Transnational Cannabis Ltd, formerly ICC International Cannabis Corp is a Canadian company which is engaged in planning, designing, building and operating cannabis production, processing, and distribution facilities. The company through its holdings is engaged in the pharmaceutical distribution, wholesale importation, research, and development, as well as working interests in industrial hemp licenses in Greece, licenses to cultivate, produce, distribute, store, and export Cannabis and Cannabis derivatives in Colombia, the Kingdom of Lesotho, Africa, and Denmark.